Interní Med. 2003; 5(7): 364-366

Přehled kardiovaskulární manifestace Marfanova syndromu a kazuistika z našeho pracoviště

MUDr. Michal Šmíd1, doc. MUDr. Petr Němec CSc1, MUDr. Tomáš Tichý2
1 Kardiochirurgická klinika FN a LF UP v Olomouci
2 Ústav patologie FN a LF UP Olomouc

Keywords: Marfan syndrome, aortic dilatation, aortic dissection, echocardiography, surgical treatment.

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šmíd M, Němec P, Tichý T. Přehled kardiovaskulární manifestace Marfanova syndromu a kazuistika z našeho pracoviště. Interní Med. 2003;5(7):364-366.

Autoři uvádějí přehled o kardiovaskulárních příznacích Marfanova syndromu, jejichdiagnostice a léčbě. Ve druhé části článku je uvedena kazuistika onemocnění.

Survey of the cardiovascular manifestation of Marfan syndrome and the case description from our workplace

The author gives a survey of cardiovascular symptoms of Marfan syndrome, their diagnostics and treatment. The case report of this disease is described in the second part of the article.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Baumgartner AW, Cameron ED, Redmond MJ, et al. Operative management of Marfan syndrome: The John Hopkins experience. Ann Thorac Surg 1999; 67: 1859-1860. Go to original source... Go to PubMed...
    2. Braunwald E. Heart Disease. WB Saunders 1997: 1669-1672.
    3. Detter CH, Mair H, Klein GH, et al. Long-term prognosis of surgically-treated aortic aneurysms and dissections in patients with and without Marfan syndrome. Eur J Card-thorac Surg 1998; 13: 416-423. Go to original source... Go to PubMed...
    4. Dietz HC, Cutting GR, Pyeritz RE. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991; 352: 337-339. Go to original source... Go to PubMed...
    5. Fleischer JK, Nousari CH, Anhalt JG et al. Immunohistochemical abnormalities of fibrillin in cardiovascular tissues in Marfan´s syndrome. Ann Thorac Surg 1997; 63: 1012-1017. Go to original source... Go to PubMed...
    6. Gott VL, Cameron DE, Pyeritz RE, et al. Composite graft repair of Marfan aneurysm of ascending aorta: results in 150 patients. J Cardiac Surg 1994; 9: 482-489. Go to original source... Go to PubMed...
    7. Kornbluth M, Schnittger I, Eyngorina I, et al. Clinical outcome in the Marfan syndrome with ascending aortic dilatation followed annually by echocardiography. Am J Cardiol 1999; 84: 753-755. Go to original source... Go to PubMed...
    8. Kouchoukos NT, Wareing TH, Murphy SF, Perrillo JB. Sixteen-year experience with aortic root replacement. Results of 172 operations. Ann Surg 1991; 214: 308-320. Go to original source... Go to PubMed...
    9. Marek D, Němec P, Heřman M, et al. Aortální disekce. Interní medicína pro praxi 2001; 7: 313-317.
    10. Pyeritz RE, McKusick VA. The Marfan syndrome: diagnosis and treatment. N Engl J Med 1979; 300: 772-777. Go to original source... Go to PubMed...
    11. Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350 kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 1986; 103: 2499-2509. Go to original source... Go to PubMed...
    12. Sakai LY, Keene DR, Glanville RW, Bachinger HP. Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue micrifibrils. J Biol Chem 1991; 266: 1463-1470. Go to original source...
    13. Yetman TA, Bornemeier AR, McCrindle WB. Long.term outcome in patients with Marfan syndrome: Is aortic dissection the only cause of sudden death? J Am Coll Cardiol 2003; 41: 329-332. Go to original source... Go to PubMed...
    14. Yetman TA, Huang P, Bornemier AR, McCrindle WB. Comparison of Outcome of the Marfan syndrome in patients diagnosed at age < 6 years versus those diagnosed at > 6 years of age. Am J Cardiol 2003; 91: 102-103. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.